Poor Science; Poorly Trained Scientists; Poor Policies: Major Deterrents to the War on Cancer
- Authors
-
-
Leslie C. Costello
School of Dentistry Department of Oncology and Diagnostic Sciences and the Greenebaum Cancer Center, University of Maryland, Baltimore, Maryland 21201, USA
-
- Keywords:
- Cancer, NIH policies, training of scientists, excessive molecular biology, holistic physiological/pathophysiological approach.
- Abstract
-
Although the availability of funding has been described as the major limitation on advances in cancer, the progress in the war on cancer has been deterred mainly by poor science, poorly trained scientists, and poor NIH policies. This is the result of NIH policies of its extreme focus on molecular biology (genomics, molecular genetics, molecular biology) identification of the molecular factors and pathways; which are required for the acceptability of treatment and preventive protocols. As such, this has influenced virtually all agencies that provide grants for medical research to adopt the NIH policies. This has impacted the funding of the research as well as the focus of the training of scientists. Directors of NCI Dr. Varmus (also Nobel Prize awardee) and Dr. Zerhouni had addressed this issue; and they rejected the necessity of molecular biology studies and information. NIH should return to the holistic physiological/pathophysiological approach to studies of cancer issues. This would provide the best approach for winning the war on cancer.
- Downloads
-
Download data is not yet available.
- References
-
Zerhouni E. The NIH roadmap. Science 2003; 332: 63-5. https://doi.org/10.1126/science.1091867
Leaf C. Why we're losing the war on cancer (and how to win it). Fortune 2004; 149(6): 76-82.
Costello LC. The effect of contemporary education and training of biomedical scientists on present and future medical research. Acad Med 2009; 84: 459-63. https://doi.org/10.1097/ACM.0b013e31819a7c6b
Perspective: Is NIH funding the "best science by the best scientists"? A critique of the NIH R01 research grant review policies. Acad Med 2010; 85(5): 775-9. https://doi.org/10.1097/ACM.0b013e3181d74256
National Institutes of Health. Enhancing Peer Review at NIH: Overview. Available at: http://enhancing-peer-review.nih.gov/index.html. Accessed January 18, 2010
Office of Extramural Research, National Institutes of Health. Encouraging Early Transition to Research Independence: Modifying the NIH New Investigator Policy to Identify Early Stage Investigators. Available at: http://grants.nih.gov/grants/guide/notice-files/NOT-OD-08-121.html. Accessed January 18, 2010.
Bernard C. An Introduction to the Study of Experimental Medicine. New York, NY: The Macmillan Company 1927.
- Downloads
- Published
- 15-08-2018
- Issue
- Vol. 7 No. 3 (2018)
- Section
- Articles
How to Cite
Similar Articles
- Shorouk G. Badr, Hesham Tawfik, Mohammad Hamdy Abo-Ryia, Ayman Mohamed El Saqa, Fatma Gharib, Total Neoadjuvant Therapy Versus Neoadjuvant Chemoradiation in Locally Advanced Rectal Cancer, Who will Gain Maximum Benefit? A Prospective Randomized Study , Journal of Cancer Research Updates: Vol. 15 No. 3 (2026)
- Wyatt Unger, Qian Tang, Danielle Summers, Wenxin Zheng, Collision Primary Tumor of the Endometrium: Large Cell Neuroendocrine Carcinoma and Endometrioid Adenocarcinoma , Journal of Cancer Research Updates: Vol. 1 No. 1 (2012)
- Lisa Billecke, Eva Maria Murga Penas, Jozef Zustin, Thorsten Derlin, Carsten Bokemeyer, Georgia Schilling, Extramedullary Plasmacytoma of the Lung - Rather a Disseminated than a Localized Disease? - A Case Report of a Primary Pulmonary Plasmacytoma Showing Distinct Signs of Systemic Spread , Journal of Cancer Research Updates: Vol. 1 No. 1 (2012)
- Bhoomika Patel, Rucha N. Acharya, Prakhar Goyal, Lalatendu Moharana, B. Senthil Kumar, Takveer Singh, S. Renuka Jyothi, Characterization of ALDH1A1 Positive Cancer Stem Cells in Glioblastoma Multiforme and Their Response to Temozolomide , Journal of Cancer Research Updates: Vol. 15 No. 3 (2026)
- Priyanka Banerjee, Samir Kumar Bandyopadhyay, A Detail Process for CAD Based Breast Cancer Detection , Journal of Cancer Research Updates: Vol. 8 No. 1 (2019)
- J.L. Layton, J.F. Renzulli II, A.M. Taber, D. Golijanin, J.E. Collins, H.H. Safran, A.E. Mega, Weekly Neoadjuvant Ixabepilone on Surgical Feasibility and Clinical Outcomes in Locally Advanced High-Risk Prostate Cancer: A Phase II Clinical Trial , Journal of Cancer Research Updates: Vol. 2 No. 4 (2013)
- Mohd Muqtader Ahmed, P. Ravi, K.E. Pravallika, Sarwat Hazeeqa, Studies on Risperidone Loaded β-Cyclodextrin Nanosponges for Managing Altered Mental Status and Delirium in Cancer Patients , Journal of Cancer Research Updates: Vol. 13 (2024)
- Yi Zheng, Ji-Ye Yin, Ying Wang, Xiang-Ping Li, Juan Chen, Chen-Yue Qian, Xiao-Ke Wen, Wei Zhang, Hong-Hao Zhou, Zhao-Qian Liu, The Association of Genetic Polymorphisms of TNFα, TNF-R1, and TNF-R2 and Lung Cancer Chemotherapy Response , Journal of Cancer Research Updates: Vol. 3 No. 4 (2014)
- Michael J. Gonzalez, Jorge R. Miranda-Massari, Jorge Duconge, Miguel J. Berdiel, Jose Olalde, Ascorbic Acid in Combination with Chemotherapeutic Agents for Cancer , Journal of Cancer Research Updates: Vol. 11 (2022)
- A. Al Qahtani, J.M.P. Holly, C.M. Perks, The Role of 5' Adenosine Monophosphate-Activated Protein Kinase in the Chemo-Sensitivity and Metabolic Behaviour of Breast Cancer Cells Exposed to Hypoxia and Hyperglycaemia , Journal of Cancer Research Updates: Vol. 11 (2022)
You may also start an advanced similarity search for this article.